Last Updated: October 3, 2025
Analyzing Management
Leadership at public companies plays a crucial role for hedge funds and asset managers during both initial due diligence and continuous risk assessment. ManagementTrack offers a consistent methodology that eliminates distractions—highlighting distinct strengths and weaknesses, identifying potential warning signs or positive indicators, and drawing a straightforward connection between CEO actions and investment outcomes.
CEO Poul’s skill gaps threaten critical operational and compliance fixes
Analysis of Integra LifeSciences CEO Mojdeh Poul
With a pattern of missed targets and a lack of relevant FDA remediation or cost management experience, Mojdeh Poul appears poorly matched for Integra’s critical operational and compliance challenges.
Management evaluated Mojdeh Poul’s track record and skillset against the following key factors for IART:
- Executing Braintree facility ramp-up for product relaunch.
- Executing cost cuts to stabilize margins and deleverage.
- Navigating supply disruptions to meet critical Q4 guidance.
- Resolving FDA warning letter via compliance plan execution.
Mojdeh Poul’s Track Record & Key Open Questions to Research
ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.
Question #1
When leading the Health Care group, did Poul prioritize executing large-scale portfolio transformations, such as the Acelity acquisition, over the detailed operational rigor required to meet the division’s own organic growth targets?
Question #2
When her division at 3M underperformed against public targets, was Poul more focused on managing the internal narrative to maintain leadership’s confidence or on driving the fundamental operational changes required to fix the performance issues?
Question #3
Considering the quality and regulatory issues that occurred within her divisions at both Medtronic and 3M, did Poul’s leadership reflect a proactive, hands-on approach to compliance and operational risk, or was she more detached, relying on her team to manage those crises reactively?
Why Do Investors Use ManagementTrack?
Q: How does ManagementTrack analyze Mojdeh Poul’s fit at IART?
A: Through proprietary career analysis and interviews with former colleagues, ManagementTrack establishes an executive’s track record, identifying core strengths and weaknesses. This profile is then evaluated against IART’s most critical challenges, including: executing the Braintree facility ramp-up, implementing cost reductions to stabilize margins, navigating supply chain disruptions, and resolving its outstanding FDA warning letter.
Q: Beyond individual track records, what other tools does ManagementTrack utilize to link executive leadership to company results?
A: ManagementTrack’s analysis extends to several quantitative indicators. Its proprietary models identify unusual instances of executive evasion during earnings call Q&A sessions. The system also scrutinizes all insider transactions to pinpoint outlier trades that may signal future stock performance. These inputs, combined with the ManagementTrack Rating—a predictive 1-to-10 score for each executive—provide investors with a distinct, data-driven perspective on how management is likely to influence upcoming company results.
Q: How extensive is ManagementTrack’s coverage universe?
A: ManagementTrack provides real-time analytical coverage on the c-suite executives of every publicly traded company.
How to Learn More
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.
Author
Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.
Sources
- Verified Career History by ManagementTrack for Mojdeh Poul
- Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
- Integra LifeSciences Holdings Corp. 10Q
- Integra LifeSciences Holdings Corp. 10K
- Integra LifeSciences Holdings Corp. Earnings Calls
- Integra LifeSciences Holdings Corp. Press Releases
Relevant Links
- For more information on ManagementTrack’s Data visit: https://paragonintel.com/management-track-data/
- For more information on ManagementTrack’s Interview & Analysis visit: https://paragonintel.com/management-track-reports/
- For more information on ManagementTrack’s Interview library visit: https://paragonintel.com/management-track-report-library/
- For more information on ManagementTrack’s Evasion Analysis visit: https://paragonintel.com/earnings-call-evasion/
- For more information on how ManagementTrack helps hedge funds and asset managers visit: https://paragonintel.com/
